Stocks360

EssilorLuxottica S.A. (ESLOY)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

Share: Facebook X WhatsApp SMS
$102.66

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$94.11B
PE (TTM)
34.13
EPS (TTM)
N/A
Dividend Yield
2.17%
Beta
0.55
Day Range
$102.25 – $103.94
52-wk Range
$79.27 – $186.81
Avg Volume
N/A
Volume
17.42K

EssilorLuxottica S.A. (ESLOY) is a publicly traded company in the Healthcare sector. Latest price: $102.66. Market cap $94.11B. Trailing PE 34.13. Dividend yield 2.17%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $183.57 2026-10-30 · $102.66 (-44.08%)

Earnings

Most Recent
Jul 28, 2026
EPS $1.92 vs est. $2.22
Missed by $0.30
Next Earnings
Feb 17, 2027
EPS estimate $1.91

Proprietary Signals

Signal snapshot temporarily unavailable.

About EssilorLuxottica S.A.

EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and supplying premium and athletic eyewear to other businesses. Conversely, the Retail segment directly offers luxury and sports eyewear to consumers through its various sales channels. The Lenses and Optical Instruments segment provides a broad spectrum of lenses, such as Varilux progressive lenses, Crizal anti-reflective and anti-smudge coatings, Transitions photochromic lenses (including the Gen 8 series), Eyezen lenses optimized for digital screen use, and Xperio polarized sun lenses, alongside corrective options from Nikon and Kodak. This segment also furnishes optical instruments, including…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)34.13×
P/S (TTM)2.89×
P/B2.17×
PEG9.90×
P/FCF (TTM)22.05×
EV / EBITDA14.52×
EV / Sales3.35×
Earnings Yield2.93%
Free Cash Flow Yield4.54%
Dividend Yield2.17%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$98.09B
Revenue (TTM)$29.29B
Net Income (TTM)$2.49B
Free Cash Flow (TTM)$4.11B
Net Debt$13.38B
Working Capital-$1.41B
Gross Margin60.84%
Operating Margin12.36%
Net Margin8.52%
Return on Equity6.39%
Return on Invested Capital4.74%

Peers

Recent News

Related

Browse more tickers: sitemap